What is the share price of Lactose (India) Ltd (LACTOSE) today?
The share price of LACTOSE as on 30th June 2025 is ₹101.55. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Lactose (India) Ltd (LACTOSE) share?
The past returns of Lactose (India) Ltd (LACTOSE) share are- Past 1 week: 0.02%
- Past 1 month: -4.57%
- Past 3 months: 13.81%
- Past 6 months: -51.18%
- Past 1 year: -44.53%
- Past 3 years: 59.35%
- Past 5 years: 435.54%
What are the peers or stocks similar to Lactose (India) Ltd (LACTOSE)?
The peers or stocks similar to Lactose (India) Ltd (LACTOSE) include:What is the market cap of Lactose (India) Ltd (LACTOSE) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Lactose (India) Ltd (LACTOSE) is ₹127.09 Cr as of 30th June 2025.What is the 52 week high and low of Lactose (India) Ltd (LACTOSE) share?
The 52-week high of Lactose (India) Ltd (LACTOSE) is ₹247.40 and the 52-week low is ₹84.27.What is the PE and PB ratio of Lactose (India) Ltd (LACTOSE) stock?
The P/E (price-to-earnings) ratio of Lactose (India) Ltd (LACTOSE) is 24.63. The P/B (price-to-book) ratio is 2.70.Which sector does Lactose (India) Ltd (LACTOSE) belong to?
Lactose (India) Ltd (LACTOSE) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Lactose (India) Ltd (LACTOSE) shares?
You can directly buy Lactose (India) Ltd (LACTOSE) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Lactose (India) Ltd
LACTOSE Share Price
101.551.54% (+1.54)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
LACTOSE Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
AvgFinancials growth has been moderate for a few years
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
LACTOSE Performance & Key Metrics
LACTOSE Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 24.58 | 2.70 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 36.56 | 6.60 | 0.83% |
LACTOSE Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
LACTOSE Company Profile
Lactose India Limited is a pharmaceutical company engaged in the business of manufacturing pharmaceutical products. The Company is principally engaged in manufacturing of lactose monohydrate
SUNPHARMA
PE Ratio
36.79
36.79
1Y Return
10.24%
10.24%
Buy Reco %
87.88
87.88
CIPLA
PE Ratio
23.07
23.07
1Y Return
1.81%
1.81%
Buy Reco %
74.19
74.19
TORNTPHARM
PE Ratio
60.36
60.36
1Y Return
22.54%
22.54%
Buy Reco %
75.00
75.00
DRREDDY
PE Ratio
18.88
18.88
1Y Return
0.99%
0.99%
Buy Reco %
55.17
55.17
ZYDUSLIFE
PE Ratio
22.01
22.01
1Y Return
7.25%
7.25%
Buy Reco %
46.43
46.43
LACTOSE Forecast
LACTOSE Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
LACTOSE
LACTOSE
Income
Balance Sheet
Cash Flow
Annual Normal View
LACTOSE Income Statement
LACTOSE Income Statement
Annual Normal View
| Financial Year | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 36.52 | 31.76 | 41.03 | 40.35 | 35.27 | 46.52 | 66.52 | 115.01 | 117.85 | 117.85 | ||||||||||
Raw Materials | 6.24 | 5.73 | 7.70 | 7.04 | 4.65 | 7.18 | 35.50 | 48.86 | 99.44 | 99.43 | ||||||||||
| Power & Fuel Cost | 5.42 | 5.32 | 6.24 | 6.30 | 5.84 | 6.89 | 7.09 | 9.69 | ||||||||||||
| Employee Cost | 8.47 | 9.07 | 11.17 | 11.88 | 10.63 | 12.25 | 6.57 | 8.72 | ||||||||||||
| Selling & Administrative Expenses | 2.67 | 2.81 | 2.90 | 2.50 | 2.80 | 2.89 | 4.28 | 8.65 | ||||||||||||
| Operating & Other expenses | 1.47 | 2.56 | 2.99 | 3.06 | 4.82 | 4.47 | 0.99 | 18.97 | ||||||||||||
EBITDA | 12.25 | 6.27 | 10.03 | 9.57 | 6.53 | 12.84 | 12.09 | 20.12 | 18.41 | 18.42 | ||||||||||
| Depreciation/Amortization | 3.41 | 3.59 | 3.60 | 3.91 | 4.36 | 4.56 | 4.69 | 5.22 | 5.39 | 5.38 | ||||||||||
| PBIT | 8.84 | 2.68 | 6.43 | 5.66 | 2.17 | 8.28 | 7.40 | 14.90 | 13.02 | 13.04 | ||||||||||
| Interest & Other Items | 4.46 | 5.46 | 5.35 | 5.56 | 5.45 | 5.12 | 5.95 | 5.24 | 6.10 | 6.11 | ||||||||||
| PBT | 4.38 | -2.78 | 1.08 | 0.10 | -3.28 | 3.16 | 1.45 | 9.66 | 6.92 | 6.93 | ||||||||||
| Taxes & Other Items | 1.58 | -1.44 | 0.36 | 0.03 | -0.79 | 0.72 | 0.26 | 2.88 | 1.76 | 1.76 | ||||||||||
| Net Income | 2.80 | -1.34 | 0.72 | 0.07 | -2.49 | 2.44 | 1.19 | 6.78 | 5.16 | 5.17 | ||||||||||
| EPS | 3.02 | -1.36 | 0.71 | 0.07 | -2.30 | 2.03 | 0.95 | 5.39 | 4.10 | 4.11 | ||||||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
LACTOSE Company Updates
LACTOSE Stock Peers
LACTOSE Past Performance & Peer Comparison
LACTOSE Past Performance & Peer Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation-basic on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation-basic on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Lactose (India) Ltd | 24.63 | 2.70 | — |
| Sun Pharmaceutical Industries Ltd | 36.79 | 5.99 | 0.95% |
| Cipla Ltd | 23.07 | 3.89 | 1.06% |
| Torrent Pharmaceuticals Ltd | 60.36 | 16.82 | 0.94% |
LACTOSE Stock Price Comparison
Compare LACTOSE with any stock or ETFCompare LACTOSE with any stock or ETF
LACTOSE
LACTOSE Holdings
LACTOSE Shareholdings
LACTOSE Promoter Holdings Trend
LACTOSE Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
LACTOSE Institutional Holdings Trend
LACTOSE Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
LACTOSE Shareholding Pattern
LACTOSE Shareholding Pattern
LACTOSE Shareholding History
LACTOSE Shareholding History
Foreign Institutions
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases containing LACTOSE stock
smallcases containing LACTOSE stock
Looks like this stock is not in any smallcase yet.
LACTOSE Events
LACTOSE Events
LACTOSE Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
LACTOSE has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
LACTOSE Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
LACTOSE has not given any dividends in last 5 years
LACTOSE Dividends
LACTOSE Dividends
Hmm, looks like data is unavailable here. Please come back after some timeLACTOSE Stock News & Opinions
LACTOSE Stock News & Opinions
Articles & Videos
Earnings
Lactose (India) standalone net profit declines 73.33% in the March 2025 quarter
Net profit of Lactose (India) declined 73.33% to Rs 0.64 crore in the quarter ended March 2025 as against Rs 2.40 crore during the previous quarter ended March 2024. Sales declined 5.54% to Rs 27.77 crore in the quarter ended March 2025 as against Rs 29.40 crore during the previous quarter ended March 2024. For the full year,net profit declined 24.01% to Rs 5.16 crore in the year ended March 2025 as against Rs 6.79 crore during the previous year ended March 2024. Sales rose 2.20% to Rs 116.40 crore in the year ended March 2025 as against Rs 113.89 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales27.7729.40 -6 116.40113.89 2 OPM %12.2420.82 -14.5716.70 - PBDT1.935.26 -63 12.3114.89 -17 PBT0.543.63 -85 6.929.67 -28 NP0.642.40 -73 5.166.79 -24 Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Lactose (India) to conduct board meeting
Lactose (India) will hold a meeting of the Board of Directors of the Company on 30 May 2025.Powered by Capital Market - Live
1 month agoCapital Market - Live
Earnings
Lactose (India) standalone net profit declines 91.63% in the December 2024 quarter
Net profit of Lactose (India) declined 91.63% to Rs 0.22 crore in the quarter ended December 2024 as against Rs 2.63 crore during the previous quarter ended December 2023. Sales declined 11.90% to Rs 28.72 crore in the quarter ended December 2024 as against Rs 32.60 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales28.7232.60 -12 OPM %10.3417.58 - PBDT1.894.80 -61 PBT0.543.60 -85 NP0.222.63 -92 Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Lactose (India) schedules board meeting
Lactose (India) will hold a meeting of the Board of Directors of the Company on 12 February 2025.Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Lactose (India) to conduct board meeting
Lactose (India) will hold a meeting of the Board of Directors of the Company on 5 December 2024Powered by Capital Market - Live
6 months agoCapital Market - Live
Corporate
Lactose (India) to convene EGM
Lactose (India) announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 15 November 2024 .Powered by Capital Market - Live
8 months agoCapital Market - Live
Corporate
Lactose (India) to hold board meeting
Lactose (India) will hold a meeting of the Board of Directors of the Company on 23 October 2024.Powered by Capital Market - Live
8 months agoCapital Market - Live
Corporate
Lactose (India) to conduct board meeting
Lactose (India) will hold a meeting of the Board of Directors of the Company on 21 October 2024.Powered by Capital Market - Live
8 months agoCapital Market - Live
Earnings
Lactose (India) standalone net profit rises 150.62% in the September 2024 quarter
Net profit of Lactose (India) rose 150.62% to Rs 2.03 crore in the quarter ended September 2024 as against Rs 0.81 crore during the previous quarter ended September 2023. Sales rose 24.64% to Rs 30.45 crore in the quarter ended September 2024 as against Rs 24.43 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales30.4524.43 25 OPM %16.4513.88 - PBDT3.942.34 68 PBT2.611.14 129 NP2.030.81 151 Powered by Capital Market - Live
8 months agoCapital Market - Live
Corporate
Lactose (India) to declare Quarterly Result
Lactose (India) will hold a meeting of the Board of Directors of the Company on 15 October 2024.Powered by Capital Market - Live
8 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 23.91%, vs industry avg of 10.2%
Over the last 5 years, market share increased from 0.02% to 0.03%
Over the last 5 years, net income has grown at a yearly rate of 136.33%, vs industry avg of 20.11%